Stewart Rahr Quotes

There are no issues more personal than prescription drugs and the high prices Americans must pay to get the medicine they need.

It's crucial to keep in mind that the hundreds of millions of dollars now spent on prescription drug advertisements are ultimately paid for by consumers in the form a higher drug prices.

The rising cost of prescription drugs has sparked a prairie fire that is spreading across our nation.

To drive down high drug costs, we need to shine a light on the negotiations between drug manufacturers, middleman negotiators and pharmacies.

It is incomprehensible that drug companies still get away with charging Americans twice as much, or more, than citizens of Canada or Europe for the exact same drugs manufactured by the exact same companies.

President Trump has exposed the dirty secret of drug pricing: There is a shadowy third player in the transaction between patients and their pharmacists: middlemen who have taken a big kickback from the drug manufacturer, which may or may not be reflected in patients' out-of-pocket costs.

We at HHS are working with President Trump on a comprehensive plan to bring down the high price of prescription drugs.

If we're going to tackle the skyrocketing cost of prescription drugs, along with so many other issues that are at the top of our community's mind, we need to reform our system and make it work for the people, not special interests and corporations.

The status quo on prescription drug prices is deeply broken and unsustainable.

When Kansans go to the pharmacy to pick up their medication, they deserve a fair deal on their drug prices.

How long do we have to keep fighting for affordable prescription drugs?

Americans pay up to 1,000 percent more to fill their prescriptions than consumers in other countries - that is an alarming statistic.

We must take action now, by permitting re-importation, to ensure that health care and prescription drugs remain accessible and affordable for everyone.

While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.

First of all, pharmaceutical costs are the single fastest-growing part of our health care budget.

If Americans could legally access prescription drugs outside the United States, then drug companies would be forced to re-evaluate their pricing strategy.

While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.

Prescription drugs today represent 60¢ on every dollar spent for health care. Ten years ago it was only 10¢.

We took away government’s power to bring down the price of drugs using its buying power. Nonetheless, the Affordable Health Care Act is a great step forward.

We can't just say the right thing on lowering the cost of prescription drugs: we have to do the right thing, too.

Competition is the best way to ensure prescription drugs are affordable.

The pricing of a pharmaceutical product is opaque and frustrating, especially for patients.

I support negotiating authority to lower prescription drug prices.

With the skyrocketing costs of prescription drugs, American taxpayers shouldn't be footing the bill for medicine going to waste.

We have taken on the health insurance industry, we have taken on the drug companies, instituting programs to lower the cost of prescription drugs.